Skip to main content
logo
Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.740
-0.020 (-0.72%)
At close: Jan 29, 2026, 4:00 PM EST
2.620
-0.120 (-4.38%)
After-hours: Jan 29, 2026, 4:05 PM EST

Genelux Revenue

In the year 2024, Genelux had annual revenue of $8.00K, down -95.29%.

Revenue (ttm)
$8.00K
Revenue Growth
-95.29%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
24
Market Cap
120.02M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.00K-162.00K-95.29%
Dec 31, 2023170.00K-10.90M-98.46%
Dec 31, 202211.07M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Karyopharm Therapeutics142.53M
Codexis52.93M
Spero Therapeutics40.55M
Sangamo Therapeutics32.88M
Whitehawk Therapeutics14.38M
Oramed Pharmaceuticals2.00M
Cardiff Oncology501.00K
Adlai Nortye-1.35M
Revenue Rankings

GNLX News

More News